A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
by on Monday, June 11th, 2012 | No Comments
Condition: Ovarian Neoplasms
Interventions: Drug: Carboplatin & paclitaxel; Biological: Carboplatin & paclitaxel & oregovomab
Sponsors: Quest PharmaTech Inc.; Quest PharmaTech Inc.
Recruiting – verified June 2012
Excerpt from: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
